Karampatakis T, Tsergouli K, Behzadi P (2023) Carbapenem-resistant Klebsiella pneumoniae: virulence factors, molecular epidemiology and latest updates in treatment options. Antibiotics (Basel) 12(2):234

Article  CAS  PubMed  Google Scholar 

Fodah RA, Scott JB, Tam HH et al (2014) Correlation of Klebsiella pneumonia comparative genetic analysis with virulence profiles in a murine respiratory disease model. PLoS ONE 9:e107394

Article  PubMed  PubMed Central  Google Scholar 

Russo TA, Marr CM (2019) Hypervirulent Klebsiella pneumoniae. ASM J Clin Microbiol Rev 32:e00001-19

Google Scholar 

Zhang J, Zhao J, Li J, Xia Y, Cao J (2021) Outer membrane vesicles derived from hypervirulent Klebsiella pneumoniae stimulate the inflammatory response. Microb Pathog 154:104841

Article  CAS  PubMed  Google Scholar 

Li J, Zheng Y, Fodah RA, Warawa JM, Ng CK (2018) Validation of 2–18F-fluorodeoxysorbitol as a potential radiopharmaceutical for imaging bacterial infection in the lung. J Nucl Med 59(1):134–139

Article  CAS  PubMed  Google Scholar 

Auletta S, Varani M, Horvat R, Galli F, Signore A, Hess S (2019) PET radiopharmaceuticals for specific bacteria imaging: a systematic review. J Clin Med 8(2):197

Article  CAS  PubMed  PubMed Central  Google Scholar 

Weinstein EA, Ordonez AA, DeMarco VP et al (2014) Imaging Enterobacteriaceae infection in vivo with 18F-fluorodeoxysorbitol positron emission tomography. Sci Transl Med 6:259ra146

Article  PubMed  PubMed Central  Google Scholar 

Kim DY, Pyo A, Ji S et al (2022) In vivo imaging of invasive aspergillosis with 18F-fluorodeoxysorbitol positron emission tomography. Nat Commun 13(1):1926

Article  CAS  PubMed  PubMed Central  Google Scholar 

Braams LB, Sijbesma JWA, Boersma HH et al (2023) Preclinical evaluation of 2-[18F]fluorodeoxysorbitol as a tracer for targeted imaging of Enterobacterales infection. Int J Med Microbiol 313(3):151581

Article  CAS  PubMed  Google Scholar 

Tanaka C, Tagami T, Kuno M et al (2023) Evaluation of clinical response to empirical antimicrobial therapy on day 7 and mortality in the intensive care unit: sub-analysis of the DIANA study Japanese data. Acute Med Surg 10(1):e842

Article  PubMed  PubMed Central  Google Scholar 

Bassetti M, Montero JG, Paiva JA (2018) When antibiotic treatment fails. Intensive Care Med 4:73–75

Article  Google Scholar 

Chang D, Sharma L, Dela Cruz CS, Zhang D (2021) Clinical epidemiology, risk factors, and control strategies of Klebsiella pneumoniae infection. Front Microbiol 12:750662

Article  PubMed  PubMed Central  Google Scholar 

Vandhana V, Saralaya KV, Bhat S, Mulki SS, Bhat KA (2022) Characterization of hypervirulent Klebsiella pneumoniae (Hv-Kp): correlation of virulence with antimicrobial susceptibility. Int J Microbiol 2022:4532707

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fodah RA (2016) In vivo monitoring of therapeutic efficacy and virulence profile by bioluminescent Klebsiella pneumoniae. Dissertation, University of Louisville. https://doi.org/10.18297/etd/2542

Fueger BJ, Czernin J, Hildebrandt I et al (2006) Impact of animal handling on the results of 18F-FDG PET studies in mice. JNM 47(6):999–1006

CAS  PubMed  Google Scholar 

Centers for Disease Control and Prevention (CDC) (2011) Office-related antibiotic prescribing for persons aged ≤14 years-United States, 1993–1994 to 2007–2008. MMWR Morb Mortal Wkly Rep 60(34):1153–1156

Google Scholar 

Hersh AL, King LM, Shapiro DJ, Hicks LA, Fleming-Dutra KE (2021) Unnecessary antibiotic prescribing in US ambulatory care settings, 2010–2015. Clin Infect Dis 72(1):133–137

PubMed  Google Scholar 

Rua M, Simón JA, Collantes M et al (2023) Infection-specific PET imaging with 18F-fluorodeoxysorbitol and 2-[18F]F-ρ-aminobenzoic acid: an extended diagnostic tool for bacterial and fungal diseases. Front Microbiol 14:1094929

Article  PubMed  PubMed Central  Google Scholar 

Roson B, Carratala J, Fernandez-Sabe N, Tubau F, Manresa F, Gudiol F (2004) Causes and factors associated with early failure in hospitalized patients with community-acquired pneumonia. Arch Intern Med 164:502–508

Article  PubMed  Google Scholar 

Blasi F, Ostermann H, Racketa J, Medina J, McBride K, Garau J (2014) Early versus later response to treatment in patients with community-acquired pneumonia: analysis of the REACH study. Respir Res 15(1):6

Article  PubMed  PubMed Central  Google Scholar 

Malherbe ST, Chen RY, Dupont P (2020) Quantitative 18F-FDG PET-CT scan characteristics correlate with tuberculosis treatment response. EJNMMI Res 10(1):8

Article  PubMed  PubMed Central  Google Scholar 

Kung BT, Seraj SM, Zadeh MZ et al (2019) An update on the role of 18F-FDG-PET/CT in major infectious and inflammatory diseases. Am J Nucl Med Mol Imaging 9(6):255–273

CAS  PubMed  PubMed Central  Google Scholar 

Nwobodo DC, Ugwu MC, Anie CO et al (2022) Antibiotic resistance: the challenges and some emerging strategies for tackling a global menace. J Clin Lab Anal 36(9):e24655

Article  Google Scholar 

Paterson IK, Hoyle A, Ochoa G, Baker-Austin C, Taylor NGH (2016) Optimising antibiotic usage to treat bacterial infections. Sci Rep 6:37853

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bertrand RL (2017) Lag phase is a dynamic, organized, adaptive, and evolvable period that prepares bacteria for cell division. J Bacteriol 201(7):e00697-e718

Google Scholar